As of 2025-11-18, the Intrinsic Value of S2Medical AB (publ) (S2M.ST) is 0.08 SEK. This S2M.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.01 SEK, the upside of S2Medical AB (publ) is 674.50%.
The range of the Intrinsic Value is 0.06 - 0.10 SEK
Based on its market price of 0.01 SEK and our intrinsic valuation, S2Medical AB (publ) (S2M.ST) is undervalued by 674.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 0.06 - 0.10 | 0.08 | 674.5% |
| DCF (Growth 10y) | 0.08 - 0.14 | 0.10 | 916.3% |
| DCF (EBITDA 5y) | 0.16 - 0.25 | 0.21 | 1954.2% |
| DCF (EBITDA 10y) | 0.18 - 0.30 | 0.24 | 2252.9% |
| Fair Value | -0.02 - -0.02 | -0.02 | -296.96% |
| P/E | 0.01 - 0.01 | 0.01 | -0.1% |
| EV/EBITDA | (0.09) - 0.15 | 0.01 | -27.9% |
| EPV | (0.06) - (0.08) | (0.07) | -771.2% |
| DDM - Stable | (0.01) - (0.03) | (0.02) | -281.4% |
| DDM - Multi | 0.05 - 0.11 | 0.07 | 557.1% |
| Market Cap (mil) | 8.36 |
| Beta | 1.09 |
| Outstanding shares (mil) | 836.14 |
| Enterprise Value (mil) | 7.07 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.07% |
| Cost of Debt | 7.00% |
| WACC | 6.31% |